CZ297968B6 - Zpusob výroby klícového meziproduktu - Google Patents

Zpusob výroby klícového meziproduktu

Info

Publication number
CZ297968B6
CZ297968B6 CZ0404699A CZ404699A CZ297968B6 CZ 297968 B6 CZ297968 B6 CZ 297968B6 CZ 0404699 A CZ0404699 A CZ 0404699A CZ 404699 A CZ404699 A CZ 404699A CZ 297968 B6 CZ297968 B6 CZ 297968B6
Authority
CZ
Czechia
Prior art keywords
key intermediate
trifluoromethyl
chloro
producing key
chiral addition
Prior art date
Application number
CZ0404699A
Other languages
English (en)
Other versions
CZ404699A3 (cs
Inventor
Yi Chen@Cheng
D. Tillyer@Richard
Tan@Lushi
Original Assignee
Merck And Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9711599A external-priority patent/GB9711599D0/en
Priority claimed from GB9727129A external-priority patent/GB9727129D0/en
Application filed by Merck And Co., Inc. filed Critical Merck And Co., Inc.
Publication of CZ404699A3 publication Critical patent/CZ404699A3/cs
Publication of CZ297968B6 publication Critical patent/CZ297968B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Zpusob výroby klícového meziproduktu pri syntéze inhibitoru reverzní transkriptázy (-)-6-chlor-4-cyklopropylethinyl-4-trifluormethyl-1,4-dihydro-2H-3,1-benzoxazin-2-onu, známého také jako DMP-266, pri kterém se vyuzívá chirální adicní reakce na 4-chlor-2-trifluormethylketoanilin organozinecnatým komplexem za poskytnutí pozadovaného alkoholu. Popisovaný zpusob je siroce vyuzitelný pri chirální adici na jakýkoliv prochirální keton.
CZ0404699A 1997-05-16 1998-05-12 Zpusob výroby klícového meziproduktu CZ297968B6 (cs)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4671397P 1997-05-16 1997-05-16
GB9711599A GB9711599D0 (en) 1997-06-05 1997-06-05 Efficient enatioselective addition reation using an organozinc reagent
US5788497P 1997-09-03 1997-09-03
GB9727129A GB9727129D0 (en) 1997-12-22 1997-12-22 Efficient enantioselective addition reaction using an organozinc reagent
US8352598P 1998-04-29 1998-04-29

Publications (2)

Publication Number Publication Date
CZ404699A3 CZ404699A3 (cs) 2000-07-12
CZ297968B6 true CZ297968B6 (cs) 2007-05-09

Family

ID=27547294

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ0404699A CZ297968B6 (cs) 1997-05-16 1998-05-12 Zpusob výroby klícového meziproduktu

Country Status (26)

Country Link
US (1) US6015926A (cs)
EP (1) EP0981520B1 (cs)
JP (1) JP3273615B2 (cs)
KR (1) KR100566683B1 (cs)
CN (1) CN1106389C (cs)
AR (1) AR011731A1 (cs)
AT (1) ATE270666T1 (cs)
AU (1) AU739250B2 (cs)
BR (1) BR9809628A (cs)
CA (1) CA2289206C (cs)
CZ (1) CZ297968B6 (cs)
DE (1) DE69824958T2 (cs)
DK (1) DK0981520T3 (cs)
EA (1) EA002192B1 (cs)
ES (1) ES2224396T3 (cs)
HR (1) HRP980266B1 (cs)
HU (1) HU226881B1 (cs)
NZ (1) NZ500526A (cs)
PL (1) PL193448B1 (cs)
PT (1) PT981520E (cs)
RS (1) RS49860B (cs)
SI (1) SI0981520T1 (cs)
SK (1) SK285446B6 (cs)
TW (1) TWI221833B (cs)
UA (1) UA59396C2 (cs)
WO (1) WO1998051676A1 (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201158B1 (en) * 1998-06-22 2001-03-13 Merck & Co., Inc. Process for making intermediate aldehydes
WO2005104711A2 (en) 2004-04-27 2005-11-10 Wyeth Purification of progesterone receptor modulators
US20090163601A1 (en) * 2007-12-21 2009-06-25 The Regents Of The University Of California (r)-2-methyl-(2,5-dimethylphenyl)propanol and (s)-(2-methyl-2,5-dimethylphenyl)propanol
US9073817B2 (en) 2008-01-31 2015-07-07 Laurus Labs Private Limited Efficient process to induce enantioselectivity in procarbonyl compounds
ZA200806473B (en) 2008-01-31 2009-04-29 Aptuit Laurus Pvt Ltd An efficient process to induce enantioselectivity in procarbonyl compounds
EP2291362A1 (en) 2008-05-01 2011-03-09 Ranbaxy Laboratories Limited Process for the preparation of efavirenz
EP2313379B1 (en) 2008-05-30 2015-03-11 Emcure Pharmaceuticals Limited Process for the preparation of efavirenz
KR100878436B1 (ko) * 2008-08-18 2009-01-13 주식회사 지씨에이치앤피 금은화 추출물을 포함하는 소화성 궤양 치료 또는 예방용 약학조성물
US20120046462A1 (en) * 2009-04-09 2012-02-23 Aleksander Warm Process for the synthesis of chiral cyclic carbamates
US8115032B2 (en) * 2009-04-09 2012-02-14 Lonza Ltd. Process for the synthesis of a propargylic alcohol
EP2417097A2 (en) * 2009-04-09 2012-02-15 Lonza Ltd. Autocatalytic process for the synthesis of chiral propargylic alcohols
US20110172419A1 (en) * 2009-04-09 2011-07-14 Aleksander Warm Process for the synthesis of cyclic carbamates
WO2011000532A2 (de) 2009-07-03 2011-01-06 Archimica Gmbh Verfahren zur enantioselektiven addition von organometallischen kohlenstoffnukleophilen an trifluormethylketone und verwendung des verfahrens in der synthese von hiv reverse transcriptase inhibitoren
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
EP2447247A1 (en) * 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of chiral propargylic alcohols
EP2441759A1 (en) 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
WO2012079235A1 (en) * 2010-12-16 2012-06-21 Lonza Ltd Process for preparing efavirenz
CN103254087B (zh) * 2013-06-07 2015-03-18 郑州大学 依非韦伦中间体的制备方法
CN105330554B (zh) 2015-02-15 2017-07-11 上海迪赛诺药业股份有限公司 手性环丙基乙炔基叔醇类化合物的合成方法
DE202015104551U1 (de) 2015-08-27 2015-12-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Reaktoren für die Herstellung von Efavirenz sowie Zwischenprodukte
NL2018412B1 (en) * 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz
CN106946718A (zh) * 2017-04-27 2017-07-14 武汉工程大学 一种合成依非韦伦中间体的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
WO1996037457A1 (en) * 1995-05-25 1996-11-28 Merck & Co., Inc. Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663169A (en) * 1992-08-07 1997-09-02 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
CA2276074A1 (en) * 1997-01-10 1998-07-16 Merck & Co., Inc. Efficient synthesis of a chiral mediator
JP3418626B2 (ja) * 1997-02-05 2003-06-23 メルク エンド カムパニー インコーポレーテッド 逆溶媒を使用する逆転写酵素阻害剤の結晶化方法
TW480253B (en) * 1997-02-12 2002-03-21 Merck & Co Inc Efficient synthesis of a 1,4-dihydro-2H-3,1-benzoxazin-2-one

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
WO1996037457A1 (en) * 1995-05-25 1996-11-28 Merck & Co., Inc. Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one

Also Published As

Publication number Publication date
KR100566683B1 (ko) 2006-04-03
KR20010012650A (ko) 2001-02-26
PL193448B1 (pl) 2007-02-28
DE69824958D1 (de) 2004-08-12
CN1106389C (zh) 2003-04-23
SI0981520T1 (en) 2004-10-31
HU226881B1 (en) 2010-01-28
JP2000513746A (ja) 2000-10-17
SK285446B6 (sk) 2007-01-04
HUP0003404A2 (hu) 2000-12-28
US6015926A (en) 2000-01-18
PL336717A1 (en) 2000-07-03
HUP0003404A3 (en) 2003-06-30
CA2289206C (en) 2008-02-05
HRP980266A2 (en) 1999-02-28
TWI221833B (en) 2004-10-11
EA199901040A1 (ru) 2000-04-24
EA002192B1 (ru) 2002-02-28
HRP980266B1 (en) 2002-10-31
EP0981520A1 (en) 2000-03-01
BR9809628A (pt) 2000-07-04
AU7470798A (en) 1998-12-08
SK156299A3 (en) 2000-07-11
ATE270666T1 (de) 2004-07-15
DE69824958T2 (de) 2005-07-14
UA59396C2 (uk) 2003-09-15
ES2224396T3 (es) 2005-03-01
YU58299A (sh) 2001-12-26
WO1998051676A1 (en) 1998-11-19
JP3273615B2 (ja) 2002-04-08
DK0981520T3 (da) 2004-11-01
NZ500526A (en) 2001-07-27
CA2289206A1 (en) 1998-11-19
CZ404699A3 (cs) 2000-07-12
CN1255919A (zh) 2000-06-07
AR011731A1 (es) 2000-08-30
EP0981520B1 (en) 2004-07-07
AU739250B2 (en) 2001-10-04
RS49860B (sr) 2008-08-07
PT981520E (pt) 2004-10-29

Similar Documents

Publication Publication Date Title
CZ297968B6 (cs) Zpusob výroby klícového meziproduktu
DK0766745T3 (da) Monoklonalt antistof, som er specifikt for humant 4-1BB samt cellelinje, som producerer dette
CA2305618A1 (en) Process for the synthesis of 1,3-diols
HRP20030760B1 (hr) Enantioselektivna sinteza intermedijernih spojeva azetidinona
CA2281380A1 (en) Hot gas reactor and process for using same
ATE144385T1 (de) Druckknopf zur arretierung von schnürsenkeln
PL392726A1 (pl) Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania
ATE219047T1 (de) Verfahren zur herstellung von optisch reinen isomeren des formoterols
WO1998027073A8 (en) Asymmetric synthesis of benzoxazinones
EA199900911A1 (ru) Асимметрический синтез бензоксазинонов через новые промежуточные соединения
BR0111472A (pt) Processo para a preparação de um composto, composto, e, forma polimórfica de um composto
AR006058A1 (es) Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido
NZ503035A (en) A process for the preparation of cyclopropylacetylene
Dumas et al. Intramolecular Michael addition of chiral imines to enoates: a new asymmetric carbocyclization reaction
DE69809055D1 (de) Verfahren zur herstellung von reinem cis-tramadol
ES2117304T3 (es) Sintesis de esfingosinas.
AU2001212914A1 (en) Friedel-craft process for the preparation of thioxanthones
AU5209699A (en) Synthesis of compounds useful in the manufacture of ketorolac
YU30499A (sh) Endotelin intermedijari dobijeni pomoću asimetrične konjugovane adicione reakcije koristeći hiralni aditiv
DE60221117D1 (de) Herstellung und verwendung von diolen
DE69918077D1 (de) Verfahren zur herstellung von spirobisphosphiten
O'Brien et al. Norephedrine-derived oxazolidines as chiral auxiliaries-stereocontrolled routes to R or S β-hydroxy phosphine oxides
DE50207388D1 (de) Verfahren zur herstellung von biperiden ii
NZ510205A (en) Process for the preparation of isoindoline involving catalytic hydrogenation of phthalonitrile
DE60324172D1 (de) Razemoselektive herstellung isolierbarer ansa-metallocen-biphenoxid-komplexe

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20180512